Massive european TB registry aims to map the disease and sharpen treatment

This study collects long-term data from tuberculosis patients across Europe to better understand the disease and its treatment. Researchers track risk factors, diagnostic details, side effects, and outcomes for both drug-sensitive and drug-resistant TB. The goal is to identify what leads to successful treatment and to develop a risk score for mortality. The registry does not test a new drug or intervention but gathers real-world evidence to guide future care.